Aulos Bioscience has filed a notice of an exempt offering of securities to raise $20 Million in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Aulos Bioscience is raising $20,000,000.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Aron Knickerbocker played a…